Search Within

Justin Taylor

Formats
  1. Journal Article (24)
  2. Meeting Abstract (20)
  3. Research Letter (3)
  4. Review (2)
  5. Book Section (1)
  6. Editorial (1)
Groups
  1. Adult Leukemia (51)
  2. Center for Hematologic Malignancies (51)
  3. Department of Medicine (51)
  4. Hematologic Malignancies, Division of (51)
  5. Executive Committee, Center for Hematologic Malignancies (39)
  6. GSK Faculty (39)

More Groups

People
  1. Omar Abdel-Wahab (34)
  2. Martin Tallman (17)
  3. Akihide Yoshimi (13)
  4. Stanley Lee (12)
  5. Eytan Stein (11)
  6. Christopher Famulare (10)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (10)
  5. 2019 (16)
  6. 2018 (10)

More Years

Publications
  1. Blood (24)
  2. Nature (3)
  3. American Journal of Hematology (2)
  4. Cancer Discovery (2)
  5. Journal of Clinical Investigation (2)
  6. Leukemia Research (2)

More Publications

Publishers
  1. American Society of Hematology (24)
  2. Nature Publishing Group (7)
  3. American Association for Cancer Research (2)
  4. American Society for Clinical Investigation (2)
  5. American Society of Clinical Oncology (2)
  6. Elsevier Inc. (2)

More Publishers

Results (51)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Hematologic malignancies arising in patients with germ cell tumors: Secondary somatic differentiation of hematopoietic malignancies from germ cell precursors
    Meeting Abstract

    Taylor, J.; Donoghue, M.; Rampal, R. K.; Tamari, R.; Tallman, M. S.; Feldman, D. R.; Taylor, B. S.; Abdel-Wahab, O. I.
    Blood (2018)

    Fulltext@MSK | Save
  • Selinexor, a first-in-class XPO1 inhibitor, is efficacious and tolerable in patients with myelodysplastic syndromes refractory to hypomethylating agents
    Meeting Abstract

    Taylor, J.; Coleman, M.; Alvarez, K.; Pichardo, J.; Sen, F.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; Tallman, M. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • High throughput droplet single-cell genotyping of transcriptomes (GoT) reveals the cell identity dependency of the transcriptional output of somatic mutations
    Meeting Abstract

    Nam, A. S.; Kim, K. T.; Chaligne, R.; Izzo, F.; Ang, C.; Omans, N.; Pastore, A.; Taylor, J.; Alonso, A.; Tam, W.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Stem cell model of hematologic diseases
    Book Section

    Taylor, J.; Abdel-Wahab, O.
    In Hoffman, R.; Benz, E. J. Jr; Silberstein, L. E.; Heslop, H. E.; Weitz, J. I.; Anastasi, J.; Salama, M. E.; Abutalib, S. A. (Eds.) Hematology: Basic Principles and Practice. 7th ed (2018)

    Fulltext@MSK | Save
  • Calculated decisions: MASCC Risk Index for febrile neutropenia
    Journal Article

    Taylor, J.
    Emergency Medicine Practice (2018)

    Fulltext@MSK | Save
  • Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies
    Journal Article

    Taylor, J.; Pavlick, D.; Yoshimi, A.; Marcelus, C.; Chung, S. S.; Hechtman, J. F.; Benayed, R.; Cocco, E.; Durham, B. H.; Bitner, L.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
    Journal Article

    Intlekofer, A. M.; Shih, A. H.; Wang, B.; Nazir, A.; Rustenburg, A. S.; Albanese, S. K.; Patel, M.; Famulare, C.; Correa, F. M.; Takemoto, N.; more...
    Nature (2018)

    Fulltext@MSK | Save
  • H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
    Journal Article

    Seiler, M.; Yoshimi, A.; Darman, R.; Chan, B.; Keaney, G.; Thomas, M.; Agrawal, A. A.; Caleb, B.; Csibi, A.; Sean, E.; more...
    Nature Medicine (2018)

    Fulltext@MSK | Save